These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6138641)

  • 21. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
    Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
    J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug resistant shigellosis in south India.
    Paniker CK; Vimala KN; Bhat P; Stephen S
    Indian J Med Res; 1978 Sep; 68():413-7. PubMed ID: 744630
    [No Abstract]   [Full Text] [Related]  

  • 23. Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children.
    Islam MR; Alam AN; Hossain MS; Mahalanabis D; Hye HK
    J Trop Pediatr; 1994 Dec; 40(6):320-5. PubMed ID: 7853434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic effectiveness of nevigramon in the complex treatment of acute dysentery].
    Gebesh VV; Koval'chuk VK; Ianushevskaia RI; Sofienko NIa; Lysak LI
    Vrach Delo; 1980 May; (5):110-3. PubMed ID: 6994350
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial.
    Dutta P; Sett A; Sarkar A; Mitra U; Saha D; Manna B; Kundu B; Gupta A
    Indian Pediatr; 1995 Jan; 32(1):13-9. PubMed ID: 8617528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysentery in Nicaragua.
    Vijil C
    N Engl J Med; 1972 Jan; 286(2):106-7. PubMed ID: 5006868
    [No Abstract]   [Full Text] [Related]  

  • 27. Outbreak of dysentery due to nalidixic acid resistant S. dysenteriae 1 at Agartala, Tripura: a hospital based study.
    Datta P; Sen D
    Indian J Public Health; 1990; 34(1):11-4. PubMed ID: 2101382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
    Cheasty T; Day M; Threlfall EJ
    Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid.
    Vinh H; Wain J; Chinh MT; Tam CT; Trang PT; Nga D; Echeverria P; Diep TS; White NJ; Parry CM
    Trans R Soc Trop Med Hyg; 2000; 94(3):323-6. PubMed ID: 10975012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiresistant Shigella infections in Bangladesh.
    Bennish M; Eusof A; Kay B; Wierzba T
    Lancet; 1985 Aug; 2(8452):441. PubMed ID: 2863461
    [No Abstract]   [Full Text] [Related]  

  • 31. Drugs for dysentery.
    Br Med J; 1970 Apr; 2(5700):36-7. PubMed ID: 5443981
    [No Abstract]   [Full Text] [Related]  

  • 32. Shigella isolation in Vellore, south India (1997-2001).
    Jesudason MV
    Indian J Med Res; 2002 Jan; 115():11-3. PubMed ID: 12424931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis.
    Miron D; Torem M; Merom R; Colodner R
    Pediatr Infect Dis J; 2004 Apr; 23(4):367-8. PubMed ID: 15071299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral kanamycin in the treatment of Shigella and Salmonella infections.
    Parry HE
    Postgrad Med J; 1967 May; ():Suppl:7-13. PubMed ID: 6042985
    [No Abstract]   [Full Text] [Related]  

  • 35. Absorption of ampicillin and nalidixic acid by infants and children with acute shigellosis.
    Nelson JD; Shelton S; Kusmiesz HT; Haltalin KC
    Clin Pharmacol Ther; 1972; 13(6):879-86. PubMed ID: 4673233
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results in the combined use of nalidixic acid with other drugs for bacillary dysentery].
    Sugano T; Tashiro F; Matsumoto T
    Nihon Densenbyo Gakkai Zasshi; 1967 Oct; 41(7):256-67. PubMed ID: 4968896
    [No Abstract]   [Full Text] [Related]  

  • 37. [Combined therapy of methacolimycin (sodium colistin methanesulfonate) and Wintomylon (nalidixic acid) in bacillary dysentery].
    Tajime H; Hirayama A; Takayama Y; Imagawa Y
    Nihon Densenbyo Gakkai Zasshi; 1968 Mar; 41(12):445-9. PubMed ID: 4971073
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of health services utilization on the recovery from dysentery.
    Myaux JA; Chakraborty J; Yunus M; Khan EH; de Francisco A
    J Trop Pediatr; 1996 Feb; 42(1):38-42. PubMed ID: 8820619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India.
    Niyogi SK; Mitra U; Dutta P
    Jpn J Infect Dis; 2001 Jun; 54(3):121-2. PubMed ID: 11544405
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of antimicrobial (nalidixic acid) therapy in shigellosis and predictive values of outcome variables in patients susceptible or resistant to it.
    Islam MR; Alam AN; Hussain MS; Mahalanabis D
    J Trop Med Hyg; 1995 Apr; 98(2):121-5. PubMed ID: 7714935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.